Resources Hub
Featured
Start with our latest thinking
Building an AI-Native Research Site From the First Patient Onward
Why sites built around AI from day one — rather than retrofitting legacy systems — hold a structural advantage sponsors are beginning to score for.
Read moreFull library
Browse everything we've published
Filter by format and open any piece for the full write-up.
- White Paper
Building an AI-Native Research Site From the First Patient Onward
Why sites built around AI from day one — rather than retrofitting legacy systems — hold a structural advantage sponsors are beginning to score for.
Jun 15, 20269 min read
- Publication
FlowAutoGate™: Validation Methodology and Concordance Results
An overview of how FlowAutoGate™ was validated against expert manual gating, and what the results mean for sponsor-grade immunogenicity data.
May 2, 20267 min read
- Blog
Why Chicago Is an Underused Advantage for Diverse Trial Enrollment
Chicago's demographic composition offers a rare combination of scale and diversity for sponsors navigating FDA diversity action plan requirements.
Apr 18, 20265 min read
- Case Study
Same-Day Immunogenicity Turnaround: What an In-House Lab Changes
A look at how pairing an in-house bioanalytical laboratory with automated flow analysis changes the sponsor timeline for vaccine and immunology trials.
Mar 22, 20266 min read
- Blog
What It Takes to Run a Responsible Psychedelic-Assisted Therapy Site
Building the physical, clinical, and regulatory infrastructure for Schedule I psychedelic research is a multi-year undertaking. Here's what we built.
Feb 10, 20266 min read
- White Paper
The Case for Physician-Led Site Operations in Device and Drug Trials
How embedding board-certified specialists as Principal Investigators and Sub-Investigators changes protocol compliance and patient safety outcomes.
Jan 28, 20268 min read
Partner with us
Let's design your next study for both speed and rigor.
Whether you need a full-service site, in-house bioanalytical support, or a FlowAutoGate™ pilot, our team can typically turn around a feasibility response within 5 business days.
